No discrete molecular drug-like target

The designation "No discrete molecular drug-like target" is a classification used in pharmacological databases, such as ChEMBL, to identify therapeutic agents that do not interact with a specific, identifiable molecular target like a protein or enzyme (Gaulton et al., 2012). Instead, these substances exert their therapeutic effects through non-specific physical or chemical mechanisms. Examples include osmotic laxatives like mannitol, which create an osmotic gradient to draw water into the intestines, and antacids like magnesium hydroxide, which neutralize gastric acid through a direct chemical reaction (StatPearls, 2023). Other agents in this category include chelating agents that bind metal ions and surfactants that alter physical properties of fluids (PubChem). Because these drugs lack a specific binding site, they do not follow traditional receptor-ligand kinetics and often require higher molar concentrations to be effective. This category is essential for maintaining the integrity of drug-target data by accounting for clinically relevant compounds that fall outside the scope of targeted molecular biology. It encompasses a wide range of treatments, from emergency toxicology treatments like activated charcoal to common over-the-counter digestive aids. Understanding this classification helps biotech analysts distinguish between targeted therapies and those relying on bulk physiological changes.

Other names

Non-molecular targetNon-specific mechanism of actionPhysical/chemical drug actionNon-protein target

Therapeutic effect is achieved via physical processes (e.g., osmosis) or direct chemical reactions (e.g., neutralization, chelation) rather than binding to a specific biological macromolecule.